$SNSS Headlines Stocks to Watch Friday: Analogic, Werner

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$SNSS Headlines

Stocks to Watch Friday: Analogic, Werner 3:36 p.m. Sept. 13, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 2:39 p.m. Sept. 13, 2012 - MarketWatch
Stocks to Watch Wednesday: Texas Instruments 4:25 p.m. Sept. 11, 2012 - David B. Wilkerson
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Sunesis Pharma up 57% in premarket 7:46 a.m. Sept. 11, 2012 - Steve Gelsi
ASCO studies shake up drug stocks 3:17 p.m. June 7, 2011 - Val Brickates Kennedy
Exelixis, Sunesis lead drug stocks lower 2:42 p.m. June 6, 2011 - Val Brickates Kennedy
Sunesis tumbles 16% in early trading 9:27 a.m. June 6, 2011 - Val Brickates Kennedy

Sunesis Pharmaceuticals Initiates Investigator-Sponsored Trial Evaluating Vosaroxin in Combination With Azacitidine in MDS 6:05 a.m. Dec. 10, 2013 - benzinga.com
Sunesis Pharmaceuticals' CEO Presents at the Piper Jaffray Healthcare Conference 2013 10:38 p.m. Dec. 3, 2013 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 4:20 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 3:20 p.m. Nov. 12, 2013 - Seeking Alpha
Sunesis Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 10:55 a.m. Nov. 12, 2013 - Seeking Alpha
Sunesis Pharmaceuticals Announces Investigator-Sponsored Phase I/II Trial Evaluating Vosaroxin in Myelodysplastic Syndrome 5:07 a.m. Oct. 28, 2013 - benzinga.com
Interview With Cowen's Dr. Eric Schmidt: These 2 Biotech Stocks Could Outperform 10:45 a.m. Oct. 16, 2013 - Seeking Alpha
2014 Isn't Looking To Good For Eli Lilly And Company 2:34 p.m. Sept. 30, 2013 - Seeking Alpha
2014 Isn't Looking To Good For Eli Lily And Company 2:34 p.m. Sept. 30, 2013 - Seeking Alpha
Sunesis' CEO Presents at BioCentury's 2013 Newsmakers in the Biotech Industry Conference (Transcript) 11:11 a.m. Sept. 27, 2013 - Seeking Alpha
Does Conatus Pharmaceuticals Have A Winner With Emricasan? 5:21 p.m. Sept. 25, 2013 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 3:56 p.m. Aug. 2, 2013 - Edgar Online - (EDG = 10Q, 10K)
Benzinga's Top Initiations 7:01 a.m. July 31, 2013 - benzinga.com
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial With no Change to Study Conduct 5:10 a.m. June 13, 2013 - benzinga.com
Sunesis Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 12:30 PM 6:20 p.m. May 21, 2013 - Seeking Alpha
Sunesis Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript 6:10 p.m. May 9, 2013 - Seeking Alpha
10-Q: SUNESIS PHARMACEUTICALS INC 3:19 p.m. May 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Sunesis Pharmaceuticals Earnings: Here’s Why the Stock is Up Now 9:16 a.m. May 9, 2013 - Wall St. Cheat Sheet
Hedge Funds Are Buying 3 Undervalued Stocks With Short Covering 3:23 p.m. March 26, 2013 - Seeking Alpha
Vosaroxin: A Promising Drug For A Difficult Disease 3:29 p.m. March 21, 2013 - Seeking Alpha


Sunesis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Evaluating Vosaroxin in Combination With Azacitidine in MDS 7:00 a.m. Dec. 10, 2013 - GlobeNewswire
Sunesis Pharmaceuticals to Present at the Piper Jaffray 25th Annual Healthcare Conference 7:00 a.m. Nov. 27, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Reports Third Quarter Financial Results and Recent Highlights 7:00 a.m. Nov. 12, 2013 - GlobeNewswire
Sunesis to Present at the 2013 Credit Suisse Annual Health Care Conference 7:00 a.m. Nov. 6, 2013 - GlobeNewswire
Sunesis to Host Conference Call on November 12th to Discuss Third Quarter Financial Results and Recent Highlights 7:00 a.m. Nov. 5, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Announces Initiation of Phase 2 Cohort of MD Anderson Sponsored Study of Vosaroxin in AML and High-Risk MDS 6:00 a.m. Oct. 30, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase I/II Trial Evaluating Vosaroxin in Myelodysplastic Syndrome 6:00 a.m. Oct. 28, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Completes Enrollment in Phase 3 VALOR Trial of Vosaroxin in AML 8:23 a.m. Sept. 25, 2013 - GlobeNewswire
Sunesis to Present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference 6:00 a.m. Sept. 19, 2013 - GlobeNewswire
Sunesis to Present at the 2013 Stifel Nicolaus Healthcare Conference 6:00 a.m. Sept. 4, 2013 - GlobeNewswire
Sunesis to Present at the 2013 Wedbush Life Sciences Management Access Conference 6:00 a.m. Aug. 7, 2013 - GlobeNewswire
Five Star Equities Issues New Research Reports on ALU, BYD, SNSS and STXS 7:50 a.m. July 31, 2013 - ACCESSWIRE
Sunesis Pharmaceuticals Reports Second Quarter Financial Results and Recent Highlights 3:01 p.m. July 29, 2013 - GlobeNewswire
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial With no Change to Study Conduct 6:00 a.m. June 13, 2013 - GlobeNewswire
Sunesis to Present at the Wells Fargo 2013 Healthcare Conference 1:25 p.m. June 12, 2013 - GlobeNewswire
Vosaroxin Review Published in Expert Opinion on Pharmacotherapy 6:01 a.m. May 30, 2013 - GlobeNewswire
Sunesis to Present at Upcoming Investor Conferences 2:30 p.m. May 10, 2013 - GlobeNewswire
Sunesis Pharmaceuticals Reports First Quarter Financial Results and Recent Highlights 6:00 a.m. May 9, 2013 - GlobeNewswire
Sunesis to Host Conference Call on May 9th to Discuss First Quarter Financial Results and Recent Highlights 6:01 a.m. May 2, 2013 - GlobeNewswire
Sunesis to Present at the Needham & Company 12th Annual Healthcare Conference 6:00 a.m. April 24, 2013 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

CRMLS Partners with Rayse to Enhance Agent-Client Transparency

Updated Category News Views 108

CRMLS Enhances Agent Value with Rayse Platform California Regional MLS (CRMLS), the leading multiple listing service in the nation, has made a significant move by integrating Rayse, a state-of-the-art agent value platform, into its offerings. This collaboration allows all CRMLS agent users to access Rayse at no cost directly through their MLS dashboard, marking a pivotal...

Continue Reading
UMG & TikTok's New Deal: A Boon for Artists?

Updated Category News Views 8

A New Era for Music Collaboration Universal Music Group and TikTok just cranked up the volume on their alliance, announcing a fresh, multi-year licensing agreement. This ain't just another handshake—it signals a seismic shift in how music gets discovered and consumed globally. Strengthened Bonds and Broadened Horizons Under this new agreement, TikTok will offer its...

Continue Reading
How an Investment in Thermo Fisher Scientific Transforms Wealth

Updated Category News Views 425

Unveiling the Growth of Thermo Fisher Scientific Investing is often seen as a pathway to wealth, and for those who placed their trust in Thermo Fisher Scientific Inc. (NYSE: TMO) two decades ago, the rewards have been substantial. This company, which specializes in scientific instrumentation, reagents, and consumables, has consistently outperformed the market. 20 Years of...

Continue Reading
European Energy A/S Launches Tender Offer for Green Bonds

Updated Category News Views 63

European Energy A/S Announces Its Tender Offer European Energy A/S has officially informed the market about a new opportunity for its bondholders. The company is targeting holders of its existing senior unsecured green bonds due in 2025 and 2026, inviting them to tender their bonds as part of a strategic financing move. Tender Offer Details Under this tender offer, which...

Continue Reading
Building a Rehabilitation Hospital: Encompass and BSA Join Forces

Updated Category News Views 170

Encompass Health and BSA Health System Join Forces Encompass Health Corp. and BSA Health System have embarked on a collaborative journey that aims to enhance rehabilitation services for patients recovering from various health challenges. This partnership marks a significant expansion in the healthcare landscape, focusing on providing dedicated rehabilitation care. A...

Continue Reading